Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

APOL1 Genotyping in Potential African American Living Kidney Donors: Utility and Cost-Effectiveness.

American journal of nephrology - 1 Jan 2020

Gudsoorkar Prakash, Anand Manish, Abu Jawdeh Bassam G

Abstract excerpt

BACKGROUND: Apolipoprotein L1 gene (APOL1) variants predispose to nondiabetic kidney disease in African American (AA) patients. Here, we share our experience with APOL1 genotyping of AA potential living kidney donors and offer a perspective on its utility and cost-effectiveness in this population. METHODS: Since May 2017, all potential AA living kidney donors at our center underwent APOL1 genotyping early in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein L1
Share to Black or African American

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cost-Benefit Analysis

Share to Donor Selection

Share to Genotype

Share to Genotyping Techniques

Share to Living Donors

Source

Identifiers

PMID: 31940609
DOI: 10.1159/000505719

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

APOL1 Genotyping in Potential African American Living Kidney Donors: Utility and Cost-Effectiveness.PMID 31940609Read ↗

Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.Semantic proximity Read ↗

African American living-kidney donors should be screened for APOL1 risk alleles.Semantic proximity Read ↗

Apolipoprotein L1: role in the evaluation of kidney transplant donors.Semantic proximity Read ↗

Introducing Genetic Tests With Uncertain Implications in Living Donor Kidney Transplantation: ApoL1 as a Case Study.Semantic proximity Read ↗

Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.Semantic proximity Read ↗

Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference.Semantic proximity Read ↗

Integrating APOL1 Kidney-risk Variant Testing in Live Kidney Donor Evaluation: An Expert Panel Opinion.Semantic proximity Read ↗

Evaluation of Potential Living Kidney Donors in the APOL1 EraSemantic proximity Read ↗

Apolipoprotein L1 Gene Effects on Kidney Transplantation.Semantic proximity Read ↗

The APOL1 gene and allograft survival after kidney transplantation.Semantic proximity Read ↗

Clinical Genetic Testing for APOL1: Are we There Yet?Semantic proximity Read ↗

The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.